Your browser doesn't support javascript.
loading
Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis Treatment.
Pizuorno Machado, Antonio; Shatila, Malek; Glitza Oliva, Isabella C; Altan, Mehmet; Siddiqui, Bilal; Zhou, Yan; Varatharajalu, Krishnavathana; Zhang, Hao Chi; Thomas, Anusha; Wang, Yinghong.
Afiliação
  • Pizuorno Machado A; Department of Internal Medicine, The University of Texas Health Science Center.
  • Shatila M; Department of Gastroenterology, Hepatology & Nutrition.
  • Glitza Oliva IC; Department of Melanoma Medical Oncology.
  • Altan M; Department of Thoracic, Head & Neck Medical Oncology.
  • Siddiqui B; Department of Genitourinary Medical Oncology.
  • Zhou Y; Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Varatharajalu K; Department of Gastroenterology, Hepatology & Nutrition.
  • Zhang HC; Department of Gastroenterology, Hepatology & Nutrition.
  • Thomas A; Department of Gastroenterology, Hepatology & Nutrition.
  • Wang Y; Department of Gastroenterology, Hepatology & Nutrition.
Am J Clin Oncol ; 46(8): 360-365, 2023 08 01.
Article em En | MEDLINE | ID: mdl-37219360

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article